GeNeuro (XPAR:GNRO) Tax Rate % : -0.03% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is GeNeuro Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. GeNeuro's Tax Expense for the six months ended in Dec. 2023 was €0.00 Mil. GeNeuro's Pre-Tax Income for the six months ended in Dec. 2023 was €-7.89 Mil. Therefore, GeNeuro's Tax Rate % for the quarter that ended in Dec. 2023 was -0.03%.

GeNeuro Tax Rate % Historical Data

The historical data trend for GeNeuro's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeNeuro Tax Rate % Chart

GeNeuro Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Rate %

Get a 7-Day Free Trial

-0.02

-0.03

GeNeuro Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Tax Rate %	Get a 7-Day Free Trial															-	-	-0.03	-0.04	-0.03

GeNeuro Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

GeNeuro's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	0.004	/	-14.753
	=	-0.03 %

GeNeuro's Tax Rate % for the quarter that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2023 )	/	Pre-Tax Income (Q: Dec. 2023 )
	=	0.002	/	-7.893
	=	-0.03 %

GeNeuro Tax Rate % Related Terms

Thank you for viewing the detailed overview of GeNeuro's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

GeNeuro Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (XPAR:GNRO) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228

Website

https://www.geneuro.com

GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).

GeNeuro Headlines

No Headlines